Forbes @Forbes
The startup is approved to conduct a clinical trial on a non-psychedelic form of ketamine for treatment-resistant depression https://t.co/VSuUfyHSya — PolitiTweet.org
Created
Thu Jan 13 02:40:02 +0000 2022
Likes
31
Retweets
7
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
Forbes @Forbes
The startup is approved to conduct a clinical trial on a non-psychedelic form of ketamine for treatment-resistant depression https://t.co/VSuUfyHSya — PolitiTweet.org